|
1
|
Jia WH, Huang QH, Liao J, et al: Trends in
incidence and mortality of nasopharyngeal carcinoma over a 20–25
year period (1978/1983–2002) in Sihui and Cangwu counties in
southern China. BMC Cancer. 6:1782006. View Article : Google Scholar
|
|
2
|
Lee AW, Poon YF, Foo W, et al:
Retrospective analysis of 5037 patients with nasopharyngeal
carcinoma treated during 1976–1985: overall survival and patterns
of failure. Int J Radiat Oncol Biol Phys. 23:261–270. 1992.
View Article : Google Scholar
|
|
3
|
Leung SF, Teo PM, Shiu WW, Tsao SY and
Leung TW: Clinical features and management of distant metastases of
nasopharyngeal carcinoma. J Otolaryngol. 20:27–29. 1991.PubMed/NCBI
|
|
4
|
Shaulian E: AP-1 - The Jun proteins:
Oncogenes or tumor suppressors in disguise? Cell Signal.
22:894–899. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao L, Huang S, Ren WH, et al: Jun
activation domain-binding protein 1 expression in oral squamous
cell carcinomas inversely correlates with the cell cycle inhibitor
p27. Med Oncol. 29:2499–2504. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song X, Tao YG, Deng XY, et al:
Heterodimer formation between c-Jun and Jun B proteins mediated by
Epstein-Barr virus encoded latent membrane protein 1. Cell Signal.
16:1153–1162. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonzalez-Villasana V, Gutierrez-Puente Y
and Tari AM: Cyclooxygenase-2 utilizes Jun N-terminal kinases to
induce invasion, but not tamoxifen resistance, in MCF-7 breast
cancer cells. Oncol Rep. 30:1506–1510. 2013.PubMed/NCBI
|
|
8
|
Wang CY, Chen CL, Tseng YL, et al: Annexin
A2 silencing induces G2 arrest of non-small cell lung cancer cells
through p53-dependent and -independent mechanisms. J Biol Chem.
287:32512–32524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qing H, Gong W, Che Y, et al:
PAK1-dependent MAPK pathway activation is required for colorectal
cancer cell proliferation. Tumour Biol. 33:985–994. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimura T, Kakuda S, Ochiai Y, et al:
Acquired radioresistance of human tumor cells by
DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene.
29:4826–4837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimura T: Acquired radioresistance of
cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat
Res. 52:539–544. 2011. View Article : Google Scholar
|
|
12
|
Guo Y, Zhu XD, Qu S, et al: Identification
of genes involved in radioresistance of nasopharyngeal carcinoma by
integrating gene ontology and protein-protein interaction networks.
Int J Oncol. 40:85–92. 2012.
|
|
13
|
Zhang JS, Li DM, Ma Y, et al:
γ-Tocotrienol induces paraptosis-like cell death in human colon
carcinoma SW620 cells. PLoS One. 8:e577792013. View Article : Google Scholar
|
|
14
|
Perri F, Bosso D, Buonerba C, Lorenzo GD
and Scarpati GD: Locally advanced nasopharyngeal carcinoma: Current
and emerging treatment strategies. World J Clin Oncol. 2:377–383.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuchi J, Kinoshita I, Shimizu Y, et al:
Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase
pathway in non-small cell lung cancer cells. Br J Cancer.
99:2013–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kajanne R, Miettinen P, Tenhunen M and
Leppä S: Transcription factor AP-1 promotes growth and
radioresistance in prostate cancer cells. Int J Oncol.
35:1175–1182. 2009.PubMed/NCBI
|
|
17
|
Golding SE, Morgan RN, Adams BR, Hawkins
AJ, Povirk LF and Valerie K: Pro-survival AKT and ERK signaling
from EGFR and mutant EGFRvIII enhances DNA double-strand break
repair in human glioma cells. Cancer Biol Ther. 8:730–738. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hatanpaa KJ, Burma S, Zhao D and Habib AA:
Epidermal growth factor receptor in glioma: signal transduction,
neuropathology, imaging, and radioresistance. Neoplasia.
12:675–684. 2010.PubMed/NCBI
|
|
19
|
Grana TM, Sartor CI and Cox AD: Epidermal
growth factor receptor autocrine signaling in RIE-1 cells
transformed by the Ras oncogene enhances radiation resistance.
Cancer Res. 63:7807–7814. 2003.PubMed/NCBI
|
|
20
|
Bergström JD, Westermark B and Heldin NE:
Epidermal growth factor receptor signaling activates met in human
anaplastic thyroid carcinoma cells. Exp Cell Res. 259:293–299.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Denning MF, Dlugosz AA, Cheng C, et al:
Cross-talk between epidermal growth factor receptor and protein
kinase C during calcium-induced differentiation of keratinocytes.
Exp Dermatol. 9:192–199. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Izquierdo M: Short interfering RNAs as a
tool for cancer gene therapy. Cancer Gene Ther. 12:217–227. 2005.
View Article : Google Scholar
|
|
23
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shinomiya N: New concepts in
radiation-induced apoptosis: ‘premitotic apoptosis’ and
‘postmitotic apoptosis’. J Cell Mol Med. 5:240–253. 2001.
View Article : Google Scholar
|
|
25
|
Shi W, Bastianutto C, Li A, et al:
Multiple dysregulated pathways in nasopharyngeal carcinoma revealed
by gene expression profiling. Int J Cancer. 119:2467–2475. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eferl R and Wagner EF: AP-1: a
double-edged sword in tumorigenesis. Nat Rev Cancer. 3:859–868.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kutuk O, Poli G and Basaga H: Resveratrol
protects against 4-hydroxynonenal-induced apoptosis by blocking JNK
and c-JUN/AP-1 signaling. Toxicol Sci. 90:120–132. 2006. View Article : Google Scholar
|
|
29
|
Hu Z, Tao YG, Yang LF, et al: Effect of
JIP on the proliferation and apoptosis of nasopharyngeal carcinoma
cells. Ai Zheng. 21:1182–1186. 2002.(In Chinese).
|
|
30
|
Nateri AS, Spencer-Dene B and Behrens A:
Interaction of phosphorylated c-Jun with TCF4 regulates intestinal
cancer development. Nature. 437:281–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su ZZ, Lee SG, Emdad L, et al: Cloning and
characterization of SARI (suppressor of AP-1, regulated by IFN).
Proc Natl Acad Sci USA. 105:20906–20911. 2008. View Article : Google Scholar : PubMed/NCBI
|
